NCT05470166View on ClinicalTrials.gov

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

January 17, 2024

Study Completion Date

April 1, 2024

Conditions
ERASLidocaineCancer of PancreasNatural Killer Cell Cytokine Production
Interventions
DRUG

Lidocaine IV

lidocaine infusion as bolus 1.5mg/kg then 2mg/kg/hr

OTHER

saline IV

saline infusion same volume as lidocaine

Trial Locations (1)

Unknown

Alexandria university, Alexandria

All Listed Sponsors
collaborator

University of Alexandria

OTHER

lead

Alexandria University

OTHER